Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
--Trial to be used in support of NDA submission-- MOUNTAIN VIEW, Calif., Feb. 16 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (NASDAQ:MAPP) today announced that the Company initiated a...
MOUNTAIN VIEW, Calif., Jan. 6 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (NASDAQ:MAPP) today announced that the company will present at the 28th Annual J.P. Morgan Healthcare Conference...
MOUNTAIN VIEW, Calif., Nov. 12 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (NASDAQ:MAPP) today announced that it has secured a committed equity financing facility under which it may sell...
MOUNTAIN VIEW, Calif., Nov. 11 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (NASDAQ:MAPP) today announced that the company will present at the Lazard Capital Markets 6th Annual Healthcare...
MOUNTAIN VIEW, Calif., Oct. 29 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (NASDAQ:MAPP) today announced that it has completed a planned interim safety review of the open-label...
-- Analysis Shows Potential of LEVADEX to Treat a Broad Spectrum of Migraine -- -- Company to Host Webcast on Monday, September 14th at 7:15 a.m. ET -- MOUNTAIN VIEW, Calif., Sept. 10...
- Investor Webcast to Discuss Phase 3 LEVADEX(TM) Data Presented in Late-Breaking Session at the 14th Congress of the International Headache Society - MOUNTAIN VIEW, Calif., Sept. 2...
- Company to Suspend Development of UDB - MOUNTAIN VIEW, Calif., July 9 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (NASDAQ:MAPP) today announced that it has received a notice of...
MOUNTAIN VIEW, Calif., Oct. 5 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. announced today that it has priced its initial public offering of 5,000,000 shares of common stock at a price of...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.2443 | 1.03918532635 | 23.5088 | 23.7531 | 23.5064 | 556 | 23.7527455 | SP |
| 4 | 0.2137 | 0.90783962208 | 23.5394 | 23.8718 | 23.2303 | 143 | 23.74476577 | SP |
| 12 | 0.5985 | 2.58479956467 | 23.1546 | 23.8718 | 22.4037 | 87 | 23.57564432 | SP |
| 26 | 1.7571 | 7.98827059465 | 21.996 | 23.8718 | 21.5984 | 325 | 22.66831722 | SP |
| 52 | 3.5531 | 17.5896039604 | 20.2 | 23.8718 | 19.93 | 225 | 22.12356104 | SP |
| 156 | 3.6131 | 17.9399205561 | 20.14 | 23.8718 | 18.9015 | 706 | 20.6762923 | SP |
| 260 | 3.6131 | 17.9399205561 | 20.14 | 23.8718 | 18.9015 | 706 | 20.6762923 | SP |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
